The global market for Tuberculosis Diagnosis and Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Tuberculosis Diagnosis and Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Tuberculosis Diagnosis and Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Tuberculosis Diagnosis and Treatment in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Tuberculosis Diagnosis and Treatment include Abbott Laboratories, Akonni Biosystems, Thermo Fisher Scientific, BD, Bio-Synth, bioMérieux, Cepheid, Eiken Chemical, Epistem, Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnosis and Treatment.

The Tuberculosis Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tuberculosis Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tuberculosis Diagnosis and Treatment Market Report

Report Metric	Details
Report Name	Tuberculosis Diagnosis and Treatment Market
Segment by Type	Laboratory Testing Nucleic Acid Tests Mantoux Test Radiography Drug Susceptibility Test
Segment by Application	Hospitals Government organizations Individual
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Akonni Biosystems, Thermo Fisher Scientific, BD, Bio-Synth, bioMérieux, Cepheid, Eiken Chemical, Epistem, Roche, GSK, Hain Lifesciences, Hologic, Labatec, Lupin, Otsuka Novel Products, QIAGEN, Sandoz, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Diagnosis and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tuberculosis Diagnosis and Treatment Market report?

Ans: The main players in the Tuberculosis Diagnosis and Treatment Market are Abbott Laboratories, Akonni Biosystems, Thermo Fisher Scientific, BD, Bio-Synth, bioMérieux, Cepheid, Eiken Chemical, Epistem, Roche, GSK, Hain Lifesciences, Hologic, Labatec, Lupin, Otsuka Novel Products, QIAGEN, Sandoz, Sanofi

What are the Application segmentation covered in the Tuberculosis Diagnosis and Treatment Market report?

Ans: The Applications covered in the Tuberculosis Diagnosis and Treatment Market report are Hospitals, Government organizations, Individual

What are the Type segmentation covered in the Tuberculosis Diagnosis and Treatment Market report?

Ans: The Types covered in the Tuberculosis Diagnosis and Treatment Market report are Laboratory Testing, Nucleic Acid Tests, Mantoux Test, Radiography, Drug Susceptibility Test

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Laboratory Testing

1.2.3 Nucleic Acid Tests

1.2.4 Mantoux Test

1.2.5 Radiography

1.2.6 Drug Susceptibility Test

1.3 Market by Application

1.3.1 Global Tuberculosis Diagnosis and Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Government organizations

1.3.4 Individual

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis Diagnosis and Treatment Market Perspective (2020-2031)

2.2 Global Tuberculosis Diagnosis and Treatment Growth Trends by Region

2.2.1 Global Tuberculosis Diagnosis and Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tuberculosis Diagnosis and Treatment Historic Market Size by Region (2020-2025)

2.2.3 Tuberculosis Diagnosis and Treatment Forecasted Market Size by Region (2026-2031)

2.3 Tuberculosis Diagnosis and Treatment Market Dynamics

2.3.1 Tuberculosis Diagnosis and Treatment Industry Trends

2.3.2 Tuberculosis Diagnosis and Treatment Market Drivers

2.3.3 Tuberculosis Diagnosis and Treatment Market Challenges

2.3.4 Tuberculosis Diagnosis and Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tuberculosis Diagnosis and Treatment Players by Revenue

3.1.1 Global Top Tuberculosis Diagnosis and Treatment Players by Revenue (2020-2025)

3.1.2 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Tuberculosis Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tuberculosis Diagnosis and Treatment Revenue

3.4 Global Tuberculosis Diagnosis and Treatment Market Concentration Ratio

3.4.1 Global Tuberculosis Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnosis and Treatment Revenue in 2024

3.5 Global Key Players of Tuberculosis Diagnosis and Treatment Head office and Area Served

3.6 Global Key Players of Tuberculosis Diagnosis and Treatment, Product and Application

3.7 Global Key Players of Tuberculosis Diagnosis and Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis Diagnosis and Treatment Breakdown Data by Type

4.1 Global Tuberculosis Diagnosis and Treatment Historic Market Size by Type (2020-2025)

4.2 Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Type (2026-2031)

5 Tuberculosis Diagnosis and Treatment Breakdown Data by Application

5.1 Global Tuberculosis Diagnosis and Treatment Historic Market Size by Application (2020-2025)

5.2 Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tuberculosis Diagnosis and Treatment Market Size (2020-2031)

6.2 North America Tuberculosis Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Tuberculosis Diagnosis and Treatment Market Size by Country (2020-2025)

6.4 North America Tuberculosis Diagnosis and Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tuberculosis Diagnosis and Treatment Market Size (2020-2031)

7.2 Europe Tuberculosis Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Tuberculosis Diagnosis and Treatment Market Size by Country (2020-2025)

7.4 Europe Tuberculosis Diagnosis and Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size (2020-2031)

8.2 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tuberculosis Diagnosis and Treatment Market Size (2020-2031)

9.2 Latin America Tuberculosis Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Tuberculosis Diagnosis and Treatment Market Size by Country (2020-2025)

9.4 Latin America Tuberculosis Diagnosis and Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size (2020-2031)

10.2 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Tuberculosis Diagnosis and Treatment Introduction

11.1.4 Abbott Laboratories Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.1.5 Abbott Laboratories Recent Development

11.2 Akonni Biosystems

11.2.1 Akonni Biosystems Company Details

11.2.2 Akonni Biosystems Business Overview

11.2.3 Akonni Biosystems Tuberculosis Diagnosis and Treatment Introduction

11.2.4 Akonni Biosystems Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.2.5 Akonni Biosystems Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Introduction

11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 BD

11.4.1 BD Company Details

11.4.2 BD Business Overview

11.4.3 BD Tuberculosis Diagnosis and Treatment Introduction

11.4.4 BD Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.4.5 BD Recent Development

11.5 Bio-Synth

11.5.1 Bio-Synth Company Details

11.5.2 Bio-Synth Business Overview

11.5.3 Bio-Synth Tuberculosis Diagnosis and Treatment Introduction

11.5.4 Bio-Synth Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.5.5 Bio-Synth Recent Development

11.6 bioMérieux

11.6.1 bioMérieux Company Details

11.6.2 bioMérieux Business Overview

11.6.3 bioMérieux Tuberculosis Diagnosis and Treatment Introduction

11.6.4 bioMérieux Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.6.5 bioMérieux Recent Development

11.7 Cepheid

11.7.1 Cepheid Company Details

11.7.2 Cepheid Business Overview

11.7.3 Cepheid Tuberculosis Diagnosis and Treatment Introduction

11.7.4 Cepheid Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.7.5 Cepheid Recent Development

11.8 Eiken Chemical

11.8.1 Eiken Chemical Company Details

11.8.2 Eiken Chemical Business Overview

11.8.3 Eiken Chemical Tuberculosis Diagnosis and Treatment Introduction

11.8.4 Eiken Chemical Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.8.5 Eiken Chemical Recent Development

11.9 Epistem

11.9.1 Epistem Company Details

11.9.2 Epistem Business Overview

11.9.3 Epistem Tuberculosis Diagnosis and Treatment Introduction

11.9.4 Epistem Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.9.5 Epistem Recent Development

11.10 Roche

11.10.1 Roche Company Details

11.10.2 Roche Business Overview

11.10.3 Roche Tuberculosis Diagnosis and Treatment Introduction

11.10.4 Roche Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.10.5 Roche Recent Development

11.11 GSK

11.11.1 GSK Company Details

11.11.2 GSK Business Overview

11.11.3 GSK Tuberculosis Diagnosis and Treatment Introduction

11.11.4 GSK Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.11.5 GSK Recent Development

11.12 Hain Lifesciences

11.12.1 Hain Lifesciences Company Details

11.12.2 Hain Lifesciences Business Overview

11.12.3 Hain Lifesciences Tuberculosis Diagnosis and Treatment Introduction

11.12.4 Hain Lifesciences Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.12.5 Hain Lifesciences Recent Development

11.13 Hologic

11.13.1 Hologic Company Details

11.13.2 Hologic Business Overview

11.13.3 Hologic Tuberculosis Diagnosis and Treatment Introduction

11.13.4 Hologic Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.13.5 Hologic Recent Development

11.14 Labatec

11.14.1 Labatec Company Details

11.14.2 Labatec Business Overview

11.14.3 Labatec Tuberculosis Diagnosis and Treatment Introduction

11.14.4 Labatec Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.14.5 Labatec Recent Development

11.15 Lupin

11.15.1 Lupin Company Details

11.15.2 Lupin Business Overview

11.15.3 Lupin Tuberculosis Diagnosis and Treatment Introduction

11.15.4 Lupin Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.15.5 Lupin Recent Development

11.16 Otsuka Novel Products

11.16.1 Otsuka Novel Products Company Details

11.16.2 Otsuka Novel Products Business Overview

11.16.3 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Introduction

11.16.4 Otsuka Novel Products Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.16.5 Otsuka Novel Products Recent Development

11.17 QIAGEN

11.17.1 QIAGEN Company Details

11.17.2 QIAGEN Business Overview

11.17.3 QIAGEN Tuberculosis Diagnosis and Treatment Introduction

11.17.4 QIAGEN Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.17.5 QIAGEN Recent Development

11.18 Sandoz

11.18.1 Sandoz Company Details

11.18.2 Sandoz Business Overview

11.18.3 Sandoz Tuberculosis Diagnosis and Treatment Introduction

11.18.4 Sandoz Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.18.5 Sandoz Recent Development

11.19 Sanofi

11.19.1 Sanofi Company Details

11.19.2 Sanofi Business Overview

11.19.3 Sanofi Tuberculosis Diagnosis and Treatment Introduction

11.19.4 Sanofi Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025)

11.19.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Akonni Biosystems

Thermo Fisher Scientific

Otsuka Novel Products

Qiagen NV

Sandoz Inc

Sanofi

List of Tables

Table 1. Global Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Laboratory Testing

Table 3. Key Players of Nucleic Acid Tests

Table 4. Key Players of Mantoux Test

Table 5. Key Players of Radiography

Table 6. Key Players of Drug Susceptibility Test

Table 7. Global Tuberculosis Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Tuberculosis Diagnosis and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Tuberculosis Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Tuberculosis Diagnosis and Treatment Market Share by Region (2020-2025)

Table 11. Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Tuberculosis Diagnosis and Treatment Market Share by Region (2026-2031)

Table 13. Tuberculosis Diagnosis and Treatment Market Trends

Table 14. Tuberculosis Diagnosis and Treatment Market Drivers

Table 15. Tuberculosis Diagnosis and Treatment Market Challenges

Table 16. Tuberculosis Diagnosis and Treatment Market Restraints

Table 17. Global Tuberculosis Diagnosis and Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Tuberculosis Diagnosis and Treatment Market Share by Players (2020-2025)

Table 19. Global Top Tuberculosis Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnosis and Treatment as of 2024)

Table 20. Ranking of Global Top Tuberculosis Diagnosis and Treatment Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Tuberculosis Diagnosis and Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Tuberculosis Diagnosis and Treatment, Headquarters and Area Served

Table 23. Global Key Players of Tuberculosis Diagnosis and Treatment, Product and Application

Table 24. Global Key Players of Tuberculosis Diagnosis and Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Tuberculosis Diagnosis and Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type (2020-2025)

Table 28. Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type (2026-2031)

Table 30. Global Tuberculosis Diagnosis and Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Application (2020-2025)

Table 32. Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Application (2026-2031)

Table 34. North America Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Tuberculosis Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Tuberculosis Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Tuberculosis Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Tuberculosis Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Tuberculosis Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Tuberculosis Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abbott Laboratories Company Details

Table 50. Abbott Laboratories Business Overview

Table 51. Abbott Laboratories Tuberculosis Diagnosis and Treatment Product

Table 52. Abbott Laboratories Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 53. Abbott Laboratories Recent Development

Table 54. Akonni Biosystems Company Details

Table 55. Akonni Biosystems Business Overview

Table 56. Akonni Biosystems Tuberculosis Diagnosis and Treatment Product

Table 57. Akonni Biosystems Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 58. Akonni Biosystems Recent Development

Table 59. Thermo Fisher Scientific Company Details

Table 60. Thermo Fisher Scientific Business Overview

Table 61. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Product

Table 62. Thermo Fisher Scientific Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 63. Thermo Fisher Scientific Recent Development

Table 64. BD Company Details

Table 65. BD Business Overview

Table 66. BD Tuberculosis Diagnosis and Treatment Product

Table 67. BD Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 68. BD Recent Development

Table 69. Bio-Synth Company Details

Table 70. Bio-Synth Business Overview

Table 71. Bio-Synth Tuberculosis Diagnosis and Treatment Product

Table 72. Bio-Synth Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 73. Bio-Synth Recent Development

Table 74. bioMérieux Company Details

Table 75. bioMérieux Business Overview

Table 76. bioMérieux Tuberculosis Diagnosis and Treatment Product

Table 77. bioMérieux Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 78. bioMérieux Recent Development

Table 79. Cepheid Company Details

Table 80. Cepheid Business Overview

Table 81. Cepheid Tuberculosis Diagnosis and Treatment Product

Table 82. Cepheid Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 83. Cepheid Recent Development

Table 84. Eiken Chemical Company Details

Table 85. Eiken Chemical Business Overview

Table 86. Eiken Chemical Tuberculosis Diagnosis and Treatment Product

Table 87. Eiken Chemical Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 88. Eiken Chemical Recent Development

Table 89. Epistem Company Details

Table 90. Epistem Business Overview

Table 91. Epistem Tuberculosis Diagnosis and Treatment Product

Table 92. Epistem Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 93. Epistem Recent Development

Table 94. Roche Company Details

Table 95. Roche Business Overview

Table 96. Roche Tuberculosis Diagnosis and Treatment Product

Table 97. Roche Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 98. Roche Recent Development

Table 99. GSK Company Details

Table 100. GSK Business Overview

Table 101. GSK Tuberculosis Diagnosis and Treatment Product

Table 102. GSK Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 103. GSK Recent Development

Table 104. Hain Lifesciences Company Details

Table 105. Hain Lifesciences Business Overview

Table 106. Hain Lifesciences Tuberculosis Diagnosis and Treatment Product

Table 107. Hain Lifesciences Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 108. Hain Lifesciences Recent Development

Table 109. Hologic Company Details

Table 110. Hologic Business Overview

Table 111. Hologic Tuberculosis Diagnosis and Treatment Product

Table 112. Hologic Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 113. Hologic Recent Development

Table 114. Labatec Company Details

Table 115. Labatec Business Overview

Table 116. Labatec Tuberculosis Diagnosis and Treatment Product

Table 117. Labatec Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 118. Labatec Recent Development

Table 119. Lupin Company Details

Table 120. Lupin Business Overview

Table 121. Lupin Tuberculosis Diagnosis and Treatment Product

Table 122. Lupin Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 123. Lupin Recent Development

Table 124. Otsuka Novel Products Company Details

Table 125. Otsuka Novel Products Business Overview

Table 126. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Product

Table 127. Otsuka Novel Products Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 128. Otsuka Novel Products Recent Development

Table 129. QIAGEN Company Details

Table 130. QIAGEN Business Overview

Table 131. QIAGEN Tuberculosis Diagnosis and Treatment Product

Table 132. QIAGEN Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 133. QIAGEN Recent Development

Table 134. Sandoz Company Details

Table 135. Sandoz Business Overview

Table 136. Sandoz Tuberculosis Diagnosis and Treatment Product

Table 137. Sandoz Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 138. Sandoz Recent Development

Table 139. Sanofi Company Details

Table 140. Sanofi Business Overview

Table 141. Sanofi Tuberculosis Diagnosis and Treatment Product

Table 142. Sanofi Revenue in Tuberculosis Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 143. Sanofi Recent Development

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

Table 147. Authors List of This Report

List of Figures

Figure 1. Tuberculosis Diagnosis and Treatment Picture

Figure 2. Global Tuberculosis Diagnosis and Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tuberculosis Diagnosis and Treatment Market Share by Type: 2024 VS 2031

Figure 4. Laboratory Testing Features

Figure 5. Nucleic Acid Tests Features

Figure 6. Mantoux Test Features

Figure 7. Radiography Features

Figure 8. Drug Susceptibility Test Features

Figure 9. Global Tuberculosis Diagnosis and Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Tuberculosis Diagnosis and Treatment Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Government organizations Case Studies

Figure 13. Individual Case Studies

Figure 14. Tuberculosis Diagnosis and Treatment Report Years Considered

Figure 15. Global Tuberculosis Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Tuberculosis Diagnosis and Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Tuberculosis Diagnosis and Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Tuberculosis Diagnosis and Treatment Market Share by Players in 2024

Figure 19. Global Top Tuberculosis Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnosis and Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Diagnosis and Treatment Revenue in 2024

Figure 21. North America Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Tuberculosis Diagnosis and Treatment Market Share by Country (2020-2031)

Figure 23. United States Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Tuberculosis Diagnosis and Treatment Market Share by Country (2020-2031)

Figure 27. Germany Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Tuberculosis Diagnosis and Treatment Market Share by Region (2020-2031)

Figure 35. China Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Tuberculosis Diagnosis and Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Tuberculosis Diagnosis and Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 51. Akonni Biosystems Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 53. BD Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 54. Bio-Synth Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 55. bioMérieux Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 56. Cepheid Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 57. Eiken Chemical Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 58. Epistem Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 59. Roche Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 60. GSK Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 61. Hain Lifesciences Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 62. Hologic Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 63. Labatec Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 64. Lupin Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 65. Otsuka Novel Products Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 66. QIAGEN Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 67. Sandoz Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 68. Sanofi Revenue Growth Rate in Tuberculosis Diagnosis and Treatment Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions